Accordingly, inhibition of STAT3 by niclosamide reverses acquired radio-resistance of NSCLC cancer xenografts and improves tumor shrinkage, while shRNA-mediated knock-down of STAT3 restores sensitivity of lung cancer cells to ionizing radiation [34,279]. The gene discussed is STAT3; the disease is lung carcinoma.